Hisaka-P Tablet is a combination analgesic formulation containing Polmacoxib 2 mg and Paracetamol 325 mg, designed for the effective management of mild to moderate pain and inflammation. Polmacoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, provides anti-inflammatory and analgesic effects by reducing the synthesis of prostaglandins involved in the inflammatory process, thereby minimizing gastrointestinal side effects commonly associated with non-selective NSAIDs. Paracetamol, a widely used analgesic and antipyretic agent, complements Polmacoxib by inhibiting central prostaglandin synthesis, contributing to pain relief and fever reduction without significant anti-inflammatory action. The combination offers a synergistic effect, enhancing analgesic efficacy while potentially reducing the required dosage of each component, thus improving tolerability. Hisaka-P Tablet is indicated for conditions such as osteoarthritis, rheumatoid arthritis, musculoskeletal pain, dental pain, and postoperative pain management. It should be used with caution in patients with hepatic or renal impairment, and contraindicated in individuals with hypersensitivity to either component or a history of gastrointestinal bleeding. Regular monitoring and adherence to prescribed dosages are essential to minimize adverse effects. Hisaka-P Tablet provides a balanced therapeutic approach for pain and inflammation, optimizing patient comfort and functional recovery.